Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio Aliagas

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Mbio|August 29, 2024
Discovery of GuaB inhibitors with efficacy against <i>Acinetobacter baumannii</i> infectionEric M Kofoed, Ignacio Aliagas, Terry Crawford, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2024
Discovery of potent dihydro-oxazinoquinolinone inhibitors of GuaB for the treatment of tuberculosisYuebiao Zhou, Ignacio Aliagas, Shumei Wang, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Pyrazolopyridine Inhibitors of B-Raf(V600E). Part 1: The Development of Selective, Orally Bioavailable, and Efficacious InhibitorsSteve Wenglowsky, Li Ren, Kateri A Ahrendt, et al.
Journal of Medicinal Chemistry|May 11, 2013
Identification of C-2 hydroxyethyl imidazopyrrolopyridines as potent JAK1 inhibitors with favorable physicochemical properties and high selectivity over JAK2Mark Zak, Christopher A Hurley, Stuart I Ward, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Mbio|August 29, 2024
Discovery of GuaB inhibitors with efficacy against <i>Acinetobacter baumannii</i> infectionEric M Kofoed, Ignacio Aliagas, Terry Crawford, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2024
Discovery of potent dihydro-oxazinoquinolinone inhibitors of GuaB for the treatment of tuberculosisYuebiao Zhou, Ignacio Aliagas, Shumei Wang, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Pyrazolopyridine Inhibitors of B-Raf(V600E). Part 1: The Development of Selective, Orally Bioavailable, and Efficacious InhibitorsSteve Wenglowsky, Li Ren, Kateri A Ahrendt, et al.
Journal of Medicinal Chemistry|May 11, 2013
Identification of C-2 hydroxyethyl imidazopyrrolopyridines as potent JAK1 inhibitors with favorable physicochemical properties and high selectivity over JAK2Mark Zak, Christopher A Hurley, Stuart I Ward, et al.
Pageof 3